MENU
文章管理
2024.05.22 Brain Health Innovation Draws Global Attention — Glac Biotech Shines at Vitafoods Europe
The halls of Geneva’s Vitafoods Europe exhibition buzzed with curiosity and discovery, and among the brightest highlights was Glac Biotech’s showcase of brain health and postbiotic innovations.
Two products stole the spotlight: PRONULIFE® Intbrain, a breakthrough probiotic ingredient designed for cognitive support, and Totipro® postbiotics PE0401 and PE0301, advanced raw materials targeting upper and lower digestive tract health. Together, they attracted the attention of global industry leaders, sparking collaboration inquiries and confirming Glac’s role as a pioneer in the probiotics and postbiotics space.
Meeting the Rising Demand for Brain Health Solutions
As the world’s population ages, brain health has become a priority for health supplement companies. Anticipating this need, Glac Biotech invested years of research and clinical trials into developing PRONULIFE® Intbrain. The results are striking: studies show improvements in cognitive function and potential benefits for Alzheimer’s disease support.
These findings resonated strongly with international brands from Europe and Asia, many of whom approached Glac during the exhibition. The response confirmed what Glac has long believed: the market is eager for safe, natural, and effective brain health solutions, and Intbrain is perfectly positioned to lead the way.
Postbiotics: The New Frontier in Health Ingredients
If brain health was one draw, postbiotics were the other. Totipro® PE0301, recently shortlisted for the NutraIngredients Europe Microbiome Modulation Award, generated immediate interest on day one of the event. Alongside it, Totipro® PE0401 showcased powerful dual applications — supporting microbiome balance from the mouth to the upper digestive tract, while strengthening regulation in the lower gut.
With postbiotics now emerging as a new frontier in health innovation, Glac Biotech’s strategic investments are paying off. During the “Innovation Tour” sessions, multiple international brands expressed interest in collaborating on new product development, reinforcing the global momentum behind Totipro®.
Expanding on the Global Stage — Next Stop: Vitafoods Asia
At Vitafoods Europe, Glac Biotech demonstrated more than just products — it showed vision. From female health probiotics to postbiotic breakthroughs and cognitive wellness innovations, Glac’s portfolio positioned itself as both versatile and science-driven.
With strong interest from global partners and a wave of collaboration opportunities, Glac is rapidly accelerating its international expansion. And the journey doesn’t stop here — in September, Glac will bring even more highlights to Vitafoods Asia, continuing its mission to shape the future of global probiotics and postbiotics.
For those who don’t want to miss what’s next, follow Glac Biotech on Facebook or LinkedIn — and join us on the path toward better global health.
Two products stole the spotlight: PRONULIFE® Intbrain, a breakthrough probiotic ingredient designed for cognitive support, and Totipro® postbiotics PE0401 and PE0301, advanced raw materials targeting upper and lower digestive tract health. Together, they attracted the attention of global industry leaders, sparking collaboration inquiries and confirming Glac’s role as a pioneer in the probiotics and postbiotics space.
Meeting the Rising Demand for Brain Health Solutions
As the world’s population ages, brain health has become a priority for health supplement companies. Anticipating this need, Glac Biotech invested years of research and clinical trials into developing PRONULIFE® Intbrain. The results are striking: studies show improvements in cognitive function and potential benefits for Alzheimer’s disease support.
These findings resonated strongly with international brands from Europe and Asia, many of whom approached Glac during the exhibition. The response confirmed what Glac has long believed: the market is eager for safe, natural, and effective brain health solutions, and Intbrain is perfectly positioned to lead the way.
Postbiotics: The New Frontier in Health Ingredients
If brain health was one draw, postbiotics were the other. Totipro® PE0301, recently shortlisted for the NutraIngredients Europe Microbiome Modulation Award, generated immediate interest on day one of the event. Alongside it, Totipro® PE0401 showcased powerful dual applications — supporting microbiome balance from the mouth to the upper digestive tract, while strengthening regulation in the lower gut.
With postbiotics now emerging as a new frontier in health innovation, Glac Biotech’s strategic investments are paying off. During the “Innovation Tour” sessions, multiple international brands expressed interest in collaborating on new product development, reinforcing the global momentum behind Totipro®.
Expanding on the Global Stage — Next Stop: Vitafoods Asia
At Vitafoods Europe, Glac Biotech demonstrated more than just products — it showed vision. From female health probiotics to postbiotic breakthroughs and cognitive wellness innovations, Glac’s portfolio positioned itself as both versatile and science-driven.
With strong interest from global partners and a wave of collaboration opportunities, Glac is rapidly accelerating its international expansion. And the journey doesn’t stop here — in September, Glac will bring even more highlights to Vitafoods Asia, continuing its mission to shape the future of global probiotics and postbiotics.
For those who don’t want to miss what’s next, follow Glac Biotech on Facebook or LinkedIn — and join us on the path toward better global health.
相關文章
發信給店家